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Abstract
Innate immunity is regulated by cholinergic signalling through nicotinic acetylcholine recep-
tors. We show here that signalling through the M3muscarinic acetylcholine receptor (M3R)
plays an important role in adaptive immunity to bothNippostrongylus brasiliensis and Salmo-
nella enterica serovar Typhimurium, as M3R-/- mice were impaired in their ability to resolve in-
fection with either pathogen. CD4 T cell activation and cytokine production were reduced in
M3R-/- mice. Immunity to secondary infection withN. brasiliensiswas severely impaired, with
reduced cytokine responses in M3R-/- mice accompanied by lower numbers of mucus-pro-
ducing goblet cells and alternatively activated macrophages in the lungs. Ex vivo lymphocyte
stimulation of cells from intact BALB/c mice infected withN. brasiliensis and S. typhimurium
with muscarinic agonists resulted in enhanced production of IL-13 and IFN-γ respectively,
which was blocked by anM3R-selective antagonist. Our data therefore indicate that choliner-
gic signalling via the M3R is essential for optimal Th1 and Th2 adaptive immunity to infection.
Author Summary
Recent data indicate that acetylcholine (ACh), a neurotransmitter which regulates a variety
of physiological functions, also influences the immune system, and that lymphocytes have
the capacity to synthesise and release ACh, controlling local innate immune responses and
suppressing inflammation. Thus far however there has been little evidence to suggest that
ACh influences adaptive immunity, characterised by activation and effector functions of
lymphocytes. We show here that during the immune response to two different pathogens,
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ACh signals through muscarinic receptors, and the M3 receptor subtype specifically, re-
sulting in enhanced activation and cytokine production by ‘helper’ T lymphocytes which
protect the host against infection.
Introduction
The role of acetylcholine (ACh) as a neurotransmitter is well established, both in the central
nervous system and the periphery, where it regulates smooth muscle contraction and many
other functions of the autonomic nervous system. Cholinergic signalling also influences the im-
mune system, most notably in the cholinergic anti-inflammatory pathway, which results in the
α7 nicotinic receptor subunit-dependent inhibition of macrophage TNF-α, IL-1β and IL-6 pro-
duction [1,2]. The influence of cholinergic signalling on adaptive immunity however is largely
unexplored, although there is evidence that nicotinic receptors influence B lymphocyte devel-
opment and activation [3]. Expression of both nicotinic receptors (nAChRs) and muscarinic
receptors (mAChRs) is affected by CD4 T cell activation in vitro [4], and mAChRs influence
differentiation of CD8 T cells in vivo [5]. To our knowledge, nothing is known about the role
of mAChRs in the adaptive response to infection.
Nippostrongylus brasiliensis is a common laboratory pathogen used to study T helper 2 im-
mune response-mediated disease resolution, and biologically closely resembles the important
human hookworms Ancylostoma duodenale andNecator americanus [6]. The Th2 response
drives resolution of infection, and IL-13 signalling through IL-4Rα is an important component
of the protective response [7]. This signalling pathway also enhances smooth muscle contractility,
which is thought to contribute to parasite expulsion [8,9]. Previous studies in our laboratory
showed delayed parasite expulsion in mice with smooth muscle cells deficient in IL-4Rα. Associ-
ated with this defect was reduced Th2 cytokine production, delayed goblet cell hyperplasia and
lower expression of the M3muscarinic receptor (M3R) in the intestine [10]. The mAChR family
consists of five subtypes (M1-M5) of G protein-coupled receptors [11], which regulate a range of
physiological activities including heart rate, smooth muscle contractility, and endocrine and exo-
crine gland secretion [12–14]. The M3R is the major mAChR expressed on smooth muscle, and
drives contractile responses in the ileum [15]. Our previous investigation determined that upre-
gulation of M3R expression induced byN. brasiliensis infection is related to IL-4Rα, sensitive to
host immunity, and may therefore also contribute to the immune response [10].
In this study, we investigated the contribution of signalling through the M3R to protective
immunity against N. brasiliensis, using both infection of M3R gene deficient mice (M3R−/−
mice) and ex vivo CD4 T cell assays. M3R deficiency significantly abrogated the ability of
BALB/c mice to launch an effective adaptive immune response to primary and secondary infec-
tion, and underlying this defect were reduced CD4 T cell-associated protective cytokine re-
sponses. Stimulation of CD4 T cells from N. brasiliensis-infected wild-type (WT) control mice
with ACh and muscarinic agonists enhanced their secretion of Th2 cytokines, and this effect
could be blocked by muscarinic and M3R-selective antagonists. A similar impairment in im-
munity was found in M3R−/−mice following systemic infection with Salmonella typhimurium.
Immunity to S. typhimurium is dependent on a robust Th1 immune response [16], with pro-
duction of IFN-γ by CD4 T cells critical for host protection and bacterial clearance [17]. In the
absence of M3R expression, strikingly higher bacterial loads were observed, which again corre-
lated with impaired CD4 T cell cytokine responses. Ex vivo stimulation of lymphocytes from
S. typhimurium-infected WT mice with ACh and muscarinic agonists enhanced IFN-γ secre-
tion, and this effect was blocked with an M3R-selective antagonist. Collectively, these results
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show for the first time that the magnitude and efficacy of the adaptive response to infection de-
pends on cholinergic signalling via the M3R.
Results
M3R expression does not influence immune cell populations or the
ability to polarise to Th1 and Th2 subsets in uninfected mice
To determine if expression of the M3R inherently influenced steady-state immune cell popula-
tions, we analysed the composition of leukocytes in secondary lymphoid tissues. There was no
significant difference in the relative proportions of B cells, CD4 and CD8 T cells, dendritic cells
or macrophages in spleens from naïve WT and M3R−/−mice (Fig. 1A), and equivalent propor-
tions of B cells, CD4 and CD8 T cells were also recorded in the mesenteric lymph nodes
(MLN) (Fig. 1A). M3R expression also did not appear to affect T cell activation status: WT and
M3R−/−mice had equal proportions of naïve (CD3+CD4+CD44loCD62Lhi) and activated
(CD3+CD4+CD44hiCD62Llo) CD4 T cells in spleen and MLN (Fig. 1B). Furthermore, in
vitro differentiation of CD4 T cells into Th1 populations by addition of IFN-γ and anti-IL-4
antibody, or Th2 populations via IL-4 and anti-IFN-γ antibody, resulted in equivalent cytokine
responses in WT and M3R−/−mice (Fig. 1C). However, anti-CD3 or PMA/ionomycin stimula-
tion of either whole MLN cell suspensions or sorted CD4 T cells for 24 hours demonstrated an
impaired ability of M3R−/− CD4+ T cells to express markers of activation when compared to
WT CD4+ cells (Fig. 1D). This finding shows that an absence of M3R expression in CD4 T
cells results in an impaired ability to respond to a non-specific activating stimulus.
Figure 1. Naïve M3R−/−mice have an equivalent composition of immune cells as WT BALB/c mice but M3R−/− CD4 T cells have an impaired ability
to activate. (A) Proportions of splenic immune cell populations (CD4, CD8, B cell, dendritic cell and macrophages) and MLN lymphoid populations (CD4,
CD8 and B cells) in naïve mice. (B) Activation status (CD44 and CD62L) of splenic and MLN CD4 T cells in naïve animals. (C) The ability of naïve cells to be
polarised ex vivo by priming to Th1 and Th2 phenotypes. (D) Ability of naïve CD4 T cells in whole MLN and CD4 only cell preparations to express activation
markers in response to stimulation with anti-CD3 or PMA/ionomycin. White bar: WT BALB/c mice; black bar: M3R−/−mice. Data are shown as mean± SEM,
n = 6; Representative of 2 separate experiments.
doi:10.1371/journal.ppat.1004636.g001
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M3R expression is required for optimal immunity to N. brasiliensis
We determined whether the M3R contributed to CD4+ T cell immune responses in anN.
brasiliensis infection. Primary infection withN. brasiliensiswas self-resolving inWT BALB/c
control mice, with parasite clearance from the small intestine by day 9 post-infection (p.i.). M3R−/−
mice exhibited delayed expulsion of worms, with significantly higher recovery of parasites from the
intestine at days 7 and 9 p.i. (Fig. 2A). M3R−/−mice have previously been shown to be refractory to
ACh-induced smooth muscle contraction [15], and intestinal smooth muscle hypercontraction is
hypothesised to be a potential effector mechanism for expulsion of nematode parasites [9]. We
observed increased ACh-driven smooth muscle contraction compared to naïve animals in infected
WTmice but not infectedM3R−/−mice (Fig. 2B), suggesting that M3R-mediated smooth muscle
hypercontractility may indeed contribute to parasite expulsion. Surprisingly, in addition to this
altered physiological response, levels of mRNA for IL-13 were reduced 4-fold in mesenteric lymph
node (MLN) cells of M3R−/−mice compared to those of WT controls at day 7 p.i. (Fig. 2C). This
was associated with reduced numbers of IL-13+ CD4 T cells (Fig. 2C). Additionally, M3R−/−mice
had reduced CD3+CD4+CD44hiCD62Llo effector memory (activated) T cells in the MLN when
compared toWTmice (Fig. 2D). Elevation of intracellular calcium (Ca2+)i is an essential event
which is necessary for CD4 T cell activation and cytokine production [18]. We tested whether
CD4 T cells fromN. brasiliensis-infectedM3R−/−mice had a reduced ability to mobilise Ca2+i. This
was the case; elevation of Ca2+i by the calcium ionophore ionomycin was significantly impaired in
M3R−/− CD4 T cells when compared toWT CD4 T cells. No difference was observed between
M3R−/− andWT CD4 T cells when extracellular calcium was chelated by EGTA, although the re-
sponse was much lower, suggesting that lack of the M3R impaired uptake of extracellular calcium
across the plasma membrane. These data indicate that M3R expression is required for optimal
T cell activation and protective immunity to primary infection byN. brasiliensis.
Cholinergic stimulation of the M3R potentiates cytokine production in
CD4 T cells
CD4 T cells isolated from the MLN of WT BALB/c mice 7 days p.i. with N. brasiliensis express-
ed mRNA for the M1, M3, M4 and M5 receptor subtypes (Fig. 3A). Cholinergic stimulation
influenced several parameters of CD4 T cell function which are important in the immune re-
sponse to infection. ACh enhanced expression of Ox40 on effector memory CD4 T cells either
directly, or in cells stimulated with sub-maximal concentrations of anti-CD3 (Fig. 3B). When
cells were treated with anti-CD3 in the presence or absence of ACh or the muscarinic agonists
muscarine and oxotremorine-M (oxo-M) all agonists enhanced production of IL-4 and IL-13
approximately 2-fold, and potentiation of cytokine production by muscarine was demonstrated
to be dose-dependent (Fig. 3C). Cholinergic enhancement of IL-13 secretion was blocked by
the pan-specific muscarinic receptor antagonist atropine, and no enhancement was observed
in cells fromM3R−/−mice (Fig. 3D). Further confirmation that the cholinergic co-stimulatory
signal acts through the M3R was provided by use of the M3R-selective antagonist J104129,
which blocked potentiation of cytokine secretion by ACh (Fig. 3D).
M3R receptor expression is required for effective recall immunity to N.
brasiliensis
To test if cholinergic regulation of CD4 T cell cytokine responses influenced adaptive immuni-
ty, we next examined how this affected the outcome of secondary infection, as this requires a
CD4 T cell-driven Th2 immune response in the lung [19,20]. Immunity to secondary infection
was strikingly abrogated in M3R−/−mice, with higher numbers of larvae recovered from the
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Figure 2. M3R deficient mice exhibit delayed clearance of a primaryN. brasiliensis infection and impaired T cell-associated protective responses.
(A) Adult worm numbers in the small intestine were elevated in M3R−/−mice in comparison to WT BALB/c on day 7 and 9 p.i. (B) Hypercontractile responses
of jejunum in response to varying doses of acetylcholine measured at day 9 p.i. were absent in M3R−/−mice. (C) Production of IL-13 by CD4 T cells is
impaired in M3R−/−mice: IL-13 mRNA levels and proportion of IL-13+ CD4 T cells from the MLN at day 7 p.i. (D) Proportion of activated (CD44hi CD62Llo)
CD4 T cells in MLN at day 7 p.i. (E) Ca2+ mobilisation in response to ionomycin in CD4 T cells in MLN at day 7 p.i. Data are shown as mean ± SEM, n = 4–6
and are representative of at least two independent experiments. Statistical significance was calculated using the Mann-Whitney two-tailed t test and denoted
by * p<0.05, ** p<0.01. White bar: WT BALB/c mice; black bar: M3R−/−mice.
doi:10.1371/journal.ppat.1004636.g002
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Figure 3. Signalling via the M3R potentiates Th2 cytokine production duringN. brasiliensis infection. (A) Detection of mRNA for M1-M5muscarinic
receptors and β-actin (βA) in CD4 T cells isolated fromMLN. (B) Ox40 expression on effector memory (CD44hiCD62Llo) subsets of CD4 T cells day 7 p.i. (C)
Cytokine secretion by MLN cells day 7 p.i. after stimulation with sub-optimal anti-CD3 and muscarinic receptor agonists (10 μM, 48 hrs) and dose response to
muscarine. Asterisks indicate significant differences between control and cholinergic stimulations. (D) IL-13 production from N. brasiliensis infected (day 7)
WT and M3R−/−MLN cells after sub-optimal anti-CD3 stimulation plus agonists ACh and Oxotremorine M (Oxo M) at 10 μM and the muscarinic receptor
antagonist atropine (AT, 100 μM) or the M3R-selective antagonist J104129 (J, 40 nM). Data are shown as mean ±SEM, n = 6 and are representative of at
least two independent experiments. *p<0.05, **p<0.01 determined by the Mann-Whitney two-tailed t test.
doi:10.1371/journal.ppat.1004636.g003
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lungs in comparison to WT controls (Fig. 4A). Levels of IL-13 and IL-4 in the lungs of M3R−/−
mice were significantly decreased (Fig. 4B), and this was reflected by diminished numbers of
IL-13+ and IL-4+ CD4 T cells (Fig. 4C), accompanied by reduced goblet cell hyperplasia and as-
sociated mucus production (Fig. 4D).
Immunity to N. brasiliensis can be accelerated by adoptive transfer of CD4 T cells sensitised
by primary infection into naïve mice [20]. We used this approach to test whether optimal adap-
tive immunity is dependent on signalling through the M3R on CD4 T cells. CD4 T cells from
previously infected WT and M3R−/−mice were adoptively transferred i/v into naïve BALB/c
mice and animals subsequently infected with N. brasiliensis. Recipients of WT CD4 T cells
showed a significant reduction in the numbers of adult worms recovered from the small intes-
tine at day 5 post infection, whereas recipients of M3R−/− CD4 T cells showed no reduction in
worm burden (Fig. 4E). This defective ability to reduce worm burden in recipients of M3R−/−
CD4 T cells was associated with an impaired induction of pulmonary alternatively activated
macrophages (AAM) as demonstrated by reduced expression of RELMα and YM1 on alveolar
macrophages (Fig. 4E). These data demonstrate that CD4 T cell responsiveness to cholinergic
signalling via the M3R is essential for effective adaptive immunity to N. brasiliensis.
Figure 4. M3R deficient mice have impairedmemory immune responses during secondary infection withN. brasiliensis. (A) Number of N.
brasiliensis larvae recovered from the lungs at day 2 post-secondary infection. (B) Levels of IL-13 and IL-4 in total lung homogenates at day 2 p.i. (C)
Intracellular IL-13 and IL-4 cytokine production in lung CD4 T cells at day 2 post secondary infection. (D) Goblet cells in the lungs visualised by Periodic Acid
Schiff (PAS) staining and enumerated by Histological Mucus Index (HMI) at day 2 p.i. White bar = WT BALB/c mice, black bar = M3R−/−mice. (E) Recovery of
adult worms from the intestines of WT BALB/c mice, alveolar macrophage numbers and expression of YM1 and RELMα after adoptive transfer of 5 × 105
CD4 cells from naïveWTmice, WTmice infected with N. brasiliensis, naïve M3R−/−mice and infected M3R−/−mice, and infection withN. brasiliensis
thereafter. Data are shown as mean ± SEM, n = 6 and are representative of two independent experiments. Statistical significance was calculated using the
Mann-Whitney two-tailed t test and denoted by *p<0.05, **p<0.01.
doi:10.1371/journal.ppat.1004636.g004
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M3R expression is required for CD4-mediated Th1 protective immunity
to S. typhimurium infection
Having established that cholinergic signalling via the M3R contributed directly to CD4 Th2-
driven immunity to nematode infection, we next tested whether this influenced immunity in a
Th1 setting. We therefore infected WT and M3R−/−mice with Salmonella typhimurium, con-
trol of which is dependent upon CD4 Th1 immune responses [16,17]. No difference in recov-
ery of bacteria was observed early in infection (day 7), but at later time points M3R−/−mice
harboured significantly higher bacterial loads in the spleen (Fig. 5A) and displayed significant
weight loss compared to WT mice (Fig. 5A). This increased susceptibility to infection correlat-
ed with reduced IFN-γ secretion by splenocytes at days 18 and 27 p.i. (Fig. 5B). Underlying this
reduction in the protective cytokine response was reduced antigen specific IFN-γ production
by CD4 T cells as demonstrated by both real-time PCR and flow cytometry analysis (Fig. 5C).
Additionally, fewer activated (CD4+CD44hiCD62Llo) T cells were found in M3R−/−mice in
comparison to WT controls infected with S. typhimurium at day 18 p.i. (Fig. 5D).
Cholinergic signalling through the M3R augments IFN-γ production ex
vivo in splenocytes from S. typhimurium infected mice
To confirm that cholinergic signalling influenced T cell cytokine responses during S. typhimurium
infection, we carried out ex vivo restimulation experiments with splenocytes removed at day 26
p.i. Both ACh andmuscarinic agonists enhanced production of IFN-γ in T cells stimulated sub-
maximally with anti-CD3. Moreover, as with ex vivo stimulation of T cells from nematode-
infected mice, the stimulatory effects were blocked by addition of atropine or the M3R-selective
inhibitor J104127 (Fig. 5E). Collectively, these data indicate that cholinergic signalling via the
M3R plays a common role in enhancing CD4 T cell activation and cytokine responses in both
Th1 and Th2 settings.
Discussion
Understanding of the influence of cholinergic signalling on immune system function has thus
far been largely restricted to innate immunity, principally focussed on dissection of the cholin-
ergic anti-inflammatory pathway. The ultimate source of ACh in this reflex response is not
neuronal, but a population of splenic noradrenaline-responsive CD4 T cells [21]. B cells also
have the capacity of synthesizing and secreting ACh and, like T cells, this can regulate innate
immunity, as B cell-derived ACh has been shown to inhibit neutrophil recruitment during ster-
ile endotoxemia [22].
In contrast, little is known about cholinergic regulation of adaptive immunity, and the role
of muscarinic receptors, despite numerous studies showing their expression on cells of the im-
mune system [23]. A number of studies have observed that administration of muscarinic an-
tagonists attenuates inflammation in vivo, suggesting a pro-inflammatory role for muscarinic
receptors [24,25], although this conflicts with others which suggest that signalling through
muscarinic receptors on vascular endothelium suppresses expression of cell adhesion mole-
cules [22].
We demonstrate here that activation of the M3R is essential for optimal immune responses
to two different pathogens; one which triggers Th2 cytokine production and another which
triggers Th1 cytokines. In the case of primary infection with N. brasiliensis, absence of the M3R
was associated with inhibition of smooth muscle contraction, reduced activation of CD4 T
cells, lower IL-13 production and delayed expulsion of parasites from the small intestine. The
impact of a lack of cholinergic signalling through the M3R was more evident during secondary
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infection, in which immunological memory in the lungs is particularly important [20] [26].
M3R deficient mice are highly susceptible to secondary infection, with a 4-fold higher recovery
of parasites on day 2 p.i., lower levels of IL-4 and IL-13 in the lungs and reduced goblet cell hy-
perplasia in the airways. Mucus secretion by goblet cells is an important mediator of immunity
to N. brasiliensis [27], and enhanced mucus production in the airways is correlated with re-
duced recovery of larvae following secondary infection [28]. Transfer of intact CD4 T cells
from a prior infection confers protective pulmonary immunity to N. brasiliensis in naïve mice
[20]. Using this approach we demonstrated that WT CD4 T cells from N. brasiliensis-infected
Figure 5. M3R deficient mice are more susceptible to S. typhimurium infection and exhibit impaired CD4 T cell responses. (A) Recovery of S.
typhimurium from the spleens of infected mice at 7, 18, 27 and 35 days p.i. and weight loss at different days p.i. (B) IFN-γ secretion by antigen-restimulated
splenocytes at different days p.i. (C) IFN-γmRNA, proportion and number of IFN-γ+ CD4 splenic T cells assayed at day 18 p.i. (D) The proportion of activated
CD4 T cells in spleens at day 18 p.i. (E) Secretion of IFN-γ by splenocytes stimulated with sub-optimal anti-CD3 after day 26 p.i. is enhanced by ACh and
muscarinic agonists (10 μM). Enhancement of IFN-γ by ACh and muscarinic agonists is blocked by atropine (AT, 100 μM) and the M3R-selective antagonist
J104129 (J, 40 nM). Data are shown as mean ± SEM, n = 5–6 and are representative of at least two independent experiments. Statistical significance was
calculated using the Mann-Whitney two-tailed t test and denoted by *p<0.05, **p<0.01.
doi:10.1371/journal.ppat.1004636.g005
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mice were able to confer significant protection which was accompanied by expansion of AAMs
in the lungs (which have recently been shown to be protective against lung stage N. brasiliensis
infection [26]) of naive recipients, an effect which was not observed with CD4 T cells from
M3R deficient mice.
The requirement of cholinergic signalling through the M3R for full CD4 T cell activation
and cytokine production is not restricted to Th2 responses, but also extends to synthesis of
IFN-γ and protection against bacterial infection. Our demonstration of an impaired response
to the calcium ionophore ionomycin in M3R−/−mice (Fig. 2) may well underlie this common
M3R-dependent effect on Th1 and Th2 driven immunity, as sustained elevation of Ca2+ is nec-
essary for the action of NFAT which in turn is required for full cytokine transcription in T cells
[18]. Muscarinic receptor signalling has been shown to cause the rapid release of Ca2+ from in-
tracellular stores and a sustained influx of external Ca2+ in neuronal cells [29] as well as T and
B cell lines [23]. Moreover, the use of antagonists suggested that this was most likely acting
through the M3R in lymphocytes [30]. Our demonstration that M3R−/− CD4 T cells from N.
brasiliensis-infected mice have an impaired ability to mobilize Ca2+ in response to ionomycin
is indicative of a profound defect in cellular function.
No difference in recovery of S. typhimurium from the spleens of WT and M3R−/−mice was
observed early in infection (day 7), when control is largely affected through innate myeloid
cells [31]. However, eventual resolution of infection is dependent on CD4 T cell-coordinated
responses [32], and higher bacterial loads in M3R−/−mice were associated with reduced IFN-γ
from day 18 onwards (Fig. 5). Others have shown indirectly that cholinergic signalling can pro-
tect against bacterial infection. Thus, administration of paraoxon, a specific inhibitor of acetyl-
cholinesterase, rendered mice more resistant to infection with S. typhimurium and enhanced
production of IL-12. These protective effects were abrogated by co-administration of an oxime
which reactivated acetylcholinesterase, implicating ACh as the agent driving potentiation of
this response [33].
We show conclusively here that cholinergic signalling through the M3R is a major contribu-
tor to immunity to parasitic and bacterial infection, and that in its absence CD4 T cell re-
sponses are significantly impaired. Moreover, muscarinic agonists enhanced cytokine
responses to both pathogens. The immunological defect in both scenarios may also be influ-
enced by the lack of M3R expression on other cell types. However, the impaired immunity to S.
typhimurium infection in M3R−/−mice was not related to altered macrophage function and
was also independent of M3R influence on B cells [34]. Our data therefore suggest that M3R-
dependent protection against infection may primarily be a function of altered CD4 T cell re-
sponsiveness. CD4 T cells also express the muscarinic receptors M1, M3 and M5. However, our
experiments with M3R-deficient mice and use of specific antagonists strongly support the con-
clusion that cholinergic enhancement of cytokine responses by CD4 T cells is driven by the
M3R. This is reinforced by pharmacological experiments which indicate that elevation of intra-
cellular calcium in T cell lines stimulated with muscarinic agonists is most likely effected
through the M3R [30].
The current study represents an important development in our understanding of choliner-
gic signalling in immunity, and may have implications for the use of functionally selective M3R
antagonists such as tiotropium, widely used clinically as bronchodilators to treat chronic ob-
structive pulmonary disease [35] and more recently asthma [36]. Several studies have shown
that tiotropium can inhibit allergen-induced eosinophilia and cytokine production [25], while
others conclude that the M3R promotes allergen-induced tissue remodelling and goblet cell hy-
perplasia without directly affecting inflammation [37], perhaps indicative of varying effects in
different animal models. As expression of the M3R has been demonstrated on other immune
cell populations including macrophages and dendritic cells (DCs) [23], these cells may also
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respond directly to ACh. Studies of human DCs have shown that cholinergic stimulation in
vitro enhanced expression of receptors involved in antigen presentation (CD86 and HLA-DR)
and influenced mixed lymphocyte reactions to these agonists. Moreover, these effects could be
blocked by atropine but not mecamylamine, suggesting that signalling was effected via musca-
rinic rather than nicotinic receptors. However, cholinergic stimulation of LPS-treated DCs led
to contrasting effects; namely a reduction in antigen presentation. These findings indicate that
complex muscarinic-dependent effects on myeloid cells exist which may differ depending on,
for example, the maturation status of cells [38]. Furthermore, a study on human DC from
nasal mucosa showed that addition of metacholine to DCs upregulated Ox40L, which can in-
duce and interact with Ox40 on activated T cells [39]. Both these data and our demonstration
that ACh upregulates expression of Ox40 on T cells provide a mechanism for cholinergic en-
hancement of T cell activation and lymphoid-myeloid cell interactions.
In summary, our data indicate that signalling through the M3R promotes CD4 T cell activa-
tion and cytokine production in two disparate murine models of infection, suggesting that
there may be potential for the development of drugs aimed at enhancing immune function for
immunoprophylaxis or other applications.
Materials and Methods
Ethics statement
All animal work was approved by the UCT Health Sciences Animal Ethics Committee (Project
licence 012/054) to be in accordance with guidelines laid down by the South African Bureau of
Standards. Research at Imperial College was approved and in accordance with regulations of
the Home Office (PPL70/6957).
Mice
M3R−/−mice were backcrossed to BALB/c background for 10 generations for this study. Mice
were bred under specific pathogen-free conditions and used aged 6–8 weeks. Protocols for all
experiments were reviewed and approved by the UCT and ICL Animal Ethics committees.
Parasite and bacterial infection
For primary parasite infection, mice were infected subcutaneously with 500 N. brasiliensis in-
fective larvae. To enumerate adult worms, mice were killed at various times post-infection (p.
i.), intestines opened longitudinally, incubated in 10 ml saline for 3 hrs at 37°C and parasites
counted under a dissecting microscope. For secondary infections, mice were treated at day 9 p.
i. with ivermectin via drinking water to eliminate parasites, rested for 28 days and re-infected
with 500 L3. Larvae were recovered from lungs by finely slicing the tissues, placing them in
5 ml saline for 3 hrs, and parasites subsequently enumerated.
Salmonella enterica serovar Typhimurium aroA− (SL3261) is an attenuated strain of STm
SL1344 (44) and was maintained and used to infect mice intraperitoneally with an infectious
dose of 5 × 105 CFU as described previously [40]. Tissue bacterial burdens were determined by
direct culturing.
In vitro CD4 T cell differentiation into Th1 or Th2 phenotype
CD4 T cells were isolated from mesenteric lymph nodes of naïve mice using flow cytometry
(>99% purity). Sorted CD4 T cells were plated at 1 × 105 cells/well on plates coated with
10 μg ml−1 anti-CD3 (BD Bioscience) and 5 μg ml−1 anti-CD28 (BD Bioscience). Th1 polari-
zation conditions: 5 ng ml−1 rIL-12 (BD Bioscience) and 50 μg ml−1 anti-IL-4 (homemade
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Clone: 11B11); Th2 polarization: 50 ng ml−1 rIL-4 (BD Bioscience) and 50 μg ml−1 anti-
IFN-γ. Cells were cultured in a final volume of 100 μl for 72 hrs, then transferred to fresh
round-bottom 96 well plates and resuspended in appropriate antibody cocktails with the addition
of 20 Uml−1 IL-2 (BD Bioscience) and cultured for another 48 hrs. Finally, cells were plated at 2 ×
105 cells/well and incubated in 96 well plates coated with 20 μg ml−1 anti-CD3 (BD Bioscience).
Supernatants were harvested after 48 hrs restimulation and used for ELISA.
Cytokine ELISA
Cytokine ELISAs were performed as previously described [41] using coating and biotinylated
detection antibodies from R&D, with the exception of homemade coating antibodies for IL-4
(11B11) and IFN-γ (ANK18KL6). Streptavidin-conjugated HRP was used for detection with a
commercially available substrate solution. MLN and lung cells were plated at 1 × 106 cells per
well in 48 well plates pre-coated with 20 ug ml−1 anti-CD3 and restimulated for 72 hrs. Ho-
mogenates of lung and intestinal sections were prepared using a Polytron homogenizer and all
samples standardized to 5 mg ml−1 protein prior to ELISA.
Calcium mobilisation assays
Changes in the cytosolic concentration of free Ca2+ were measured using the calcium indicator
Fura-4-AM. Cellular suspensions of MLN were stained with anti-CD3 and anti-CD4 antibodies
and then washed and resuspended to a concentration of 0.5 × 107 cells/ml in Ca2+ flux buffer
(Hank’s balanced salt solution (HBSS) containing 1 mM CaCl2, 1 mMMgCl2, and 0.1% BSA),
and labelled with 5 μM Fura-4-AM for 30 min at 37°C in the dark. Labelled cells were washed
in Ca2+ flux buffer. Changes in Ca2+ in CD3+CD4+ cells following stimulation with 10 μM
ionomycin in the presence or absence of 10 μMEGTA were monitored by flow cytometry.
Cholinergic stimulation
Cells were stimulated with 0.1 μg ml−1 (sub-optimal) anti-CD3, 10 μMACh + 10 μM
BW284C51, a specific inhibitor of acetylcholinesterases used to increase the half-life of
acetylcholine (ACh), 10 μMOxotremorine M (Oxo M), 10 μMmuscarine or buffer controls
for 48 hrs. The muscarinic receptor antagonist atropine (AT) was used at a concentration of
100 μM, and the M3R-selective antagonist J104129 [42] at a concentration of 40 nM. Superna-
tants were analysed for cytokines as described.
Measurement of intestinal contraction
Jejunum sections (1 cm) were obtained and hooked onto a force transducer, placed in PBS
maintained at 37°C in an organ bath, and stimulated with ACh from 10−9 M to 10−3 M. In be-
tween stimulations, the intestinal segment was allowed to return to baseline contraction (at
least 5 min). All measurements were recorded using the Powerlab acquisition unit and analysed
using the Chart5 program. The amplitude was measured as the difference between the peak
and trough of the contraction and reported in millinewtons (mN).
Flow cytometry
Single cell suspensions were prepared and 1 × 106 cells incubated in PBS + 0.1% BSA, 1% nor-
mal rat serum and appropriate antibody cocktails. Cell populations were determined and ac-
quired on a BD FACS Fortessa (Becton Dickinson). Cell populations were identified by the
following antibody staining strategies: CD4 T cells: CD3+CD4+; CD8 T cells: CD3+CD8+; B
cells: CD19+B220+; Macrophages: CD11b+F4/80+; Dendritic cells: CD11c+. CD4 T cells
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populations were additionally stratified into naïve (CD44loCD62Lhi) and activated
(CD44hiCD62Llo) T cell populations and stained for Ox40 (CD134). Alternatively activated
macrophages were characterised by staining for YM1 and RELMα. Intra-cellular cytokine
staining was carried on MLN, spleen or lung cells. Cells were re-suspended in complete media
(IMDM (GIBCO/Invitrogen; Carlsbad, CA), 10% FCS, P/S) at 2.5×107/ml and stimulated with
either10 μg/ml PMA/ionomycin or antigen and GolgiStop (as per manufacturer’s protocol; BD
Pharmingen) at 37°C for 4 hours. After re-stimulation, cells were surface stained for CD3, CD4
then fixed and permeabilized with Cytofix/
Cytoperm Plus (as per manufacturer’s instructions; BD Pharmingen). Intracellular staining
was performed by staining cells with either IL-13, IFN-γ or appropriately labeled isotype con-
trol. All analyses were performed with FlowJo software.
Adoptive transfer of CD4 T cells
CD4 T cells were purified fromMLNs by positive selection using CD4 MACS beads (L3T4,
MACS Miltenyi) according to the manufacturer’s protocol. Cells were further purified by flow
cytometry to obtain purities above 95%, and 5 × 105 purified CD4 T cells from infected or
naive animals transferred into naive WT or M3R−/−mice intravenously. Recipient mice were
infected 24 hrs later with 500 L3 and killed 5 days post infection.
cDNA synthesis and RT-PCR
RNA was extracted using the Qiagen RNeasy Mini kit as per manufacturer’s protocols. RNA
was converted to cDNA using random primers and Superscript II. The following primer pairs
were used M1R: 5’-GGACAACAACACCAGAGGAGA-3’; 5’-GAGGTCACTTTAGGGTAG
GG-3’; M2R: 5’-TGAAAACACGGTTTCCACTTC-3’, 5’-GATGGAGGAGGCTTCTTTTTG-
3’; M3R: 5’-TTTACATGCCTGTCACCATCA-3’, 5’-ACAGCCACCATACTTCCTCCT-3’;
M4R: 5’-TGCCTCTGTCATGAACCTTCT-3’, 5’-TGGTTATCAGGCACTGTCCTC-3’; M5R:
5’-CTCTGCTGGCAGTACTTGGTC-3’, 5’-GTGAGCCGGTTTTCTCTTCTT-3’; β-actin: 5’-
TGGAATCCTGTGGCATCCATGAAAC-3’, 5’-TAAAACGCAGCTCAGTAACAGTCCG-3’;
IL-13: 5’-CTCCCTCTGACCCTTAAGGAG-3’; 5’-GAAGGGGCCGTGGCGAAACAG-3’
Histology
Lung and intestinal sections were fixed with 4% formalin in PBS solution, embedded in wax
and cut into sections, then stained with Periodic Acid Schiff (PAS) stain to distinguish mucus-
producing goblet cells. The histological mucus index (HMI) was used to quantify pulmonary
goblet cell hyperplasia in individual mice, as described before (49).
Statistics
Values are expressed as mean ± standard deviation and significant differences were determined
using either Mann-Whitney U test or ANOVA (GraphPad Prism4).
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